Ingela Wiklund

1 ta ish

GlaxoSmithKline (United Kingdom)

1. Multinational Trials—Recommendations on the Translations Required, Approaches to Using the Same Language in Different Countries, and the Approaches to Support Pooling the Data: The ISPOR Patient-Reported Outcomes Translation and Linguistic Validation Good Research Practices Task Force Report

   D Wild, Sonya Eremenco, I Mear +9

   MaqolaOAOchiq kirish20082 iqtibos

   ABIABI:AkademIndex/2026.other.177339